
Evolutionary Genomics, Inc. – OTC:FNAM
Evolutionary Genomics stock price today
Evolutionary Genomics stock price monthly change
Evolutionary Genomics stock price quarterly change
Evolutionary Genomics stock price yearly change
Evolutionary Genomics key metrics
Market Cap | 5.32K |
Enterprise value | 7.28M |
P/E | -2 |
EV/Sales | N/A |
EV/EBITDA | -7.97 |
Price/Sales | N/A |
Price/Book | -0.73 |
PEG ratio | -0.01 |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEvolutionary Genomics stock price history
Evolutionary Genomics stock forecast
Evolutionary Genomics financial statements
Dec 2022 | 0 | -254.76K | |
---|---|---|---|
Mar 2023 | 0 | 0 | |
Jun 2023 | 0 | 0 | |
Sep 2023 | 0 | 0 |
Payout ratio | 0% |
---|
2018 | 16.48% |
---|---|
2019 | |
2020 | |
2021 | |
2022 |
Dec 2022 | 2353710 | 7.94M | 337.58% |
---|---|---|---|
Mar 2023 | 0 | 0 | |
Jun 2023 | 0 | 0 | |
Sep 2023 | 0 | 0 |
Dec 2022 | -188.48K | 0 | 0 |
---|---|---|---|
Mar 2023 | 0 | 0 | 0 |
Jun 2023 | 0 | 0 | 0 |
Sep 2023 | 0 | 0 | 0 |
Evolutionary Genomics alternative data
Aug 2023 | 2 |
---|---|
Sep 2023 | 2 |
Oct 2023 | 2 |
Nov 2023 | 2 |
Dec 2023 | 2 |
Jan 2024 | 2 |
Feb 2024 | 2 |
Mar 2024 | 2 |
Apr 2024 | 2 |
May 2024 | 2 |
Jun 2024 | 2 |
Jul 2024 | 2 |
Evolutionary Genomics other data
Period | Buy | Sel |
---|---|---|
Oct 2014 | 0 | 3061802 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | MESSIER WALTER officer: Secretary / Treasurer | Stock Option (right to buy) | 100,000 | $0.55 | $55,000 | ||
Option | MESSIER WALTER officer: Secretary / Treasurer | Common Stock | 100,000 | $0.55 | $55,000 | ||
Option | ORNDORFF VIRGINIA P. director | Stock Option (right to buy) | 20,000 | $0.55 | $11,000 | ||
Option | ORNDORFF VIRGINIA P. director | Common Stock | 20,000 | $0.55 | $11,000 | ||
Option | WARNECKE STEVE B director, 10 perc.. | Stock Option (right to buy) | 66,667 | $0.55 | $36,667 | ||
Option | WARNECKE STEVE B director, 10 perc.. | Common Stock | 66,667 | $0.55 | $36,667 | ||
Sale | SCHWARTZ SANFORD other: See Remarks | Common Stock | 1,530,901 | N/A | N/A | ||
Sale | FRIESS MICHAEL other: See Remarks | Common Stock | 1,530,901 | N/A | N/A |
Insider | Compensation |
---|---|
Mr. Steve B. Warnecke (1957) Chairman, Chief Executive Officer, Pres & Chief Financial Officer | $210,000 |
Dr. Walter Messier (1956) Founder, Chief Technology Officer, Treasurer & Sec. | $200,800 |
-
What's the price of Evolutionary Genomics stock today?
One share of Evolutionary Genomics stock can currently be purchased for approximately $0.65.
-
When is Evolutionary Genomics's next earnings date?
Unfortunately, Evolutionary Genomics's (FNAM) next earnings date is currently unknown.
-
Does Evolutionary Genomics pay dividends?
No, Evolutionary Genomics does not pay dividends.
-
How much money does Evolutionary Genomics make?
Evolutionary Genomics has a market capitalization of 5.32K.
-
What is Evolutionary Genomics's stock symbol?
Evolutionary Genomics, Inc. is traded on the OTC under the ticker symbol "FNAM".
-
What is Evolutionary Genomics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Evolutionary Genomics?
Shares of Evolutionary Genomics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Evolutionary Genomics's key executives?
Evolutionary Genomics's management team includes the following people:
- Mr. Steve B. Warnecke Chairman, Chief Executive Officer, Pres & Chief Financial Officer(age: 68, pay: $210,000)
- Dr. Walter Messier Founder, Chief Technology Officer, Treasurer & Sec.(age: 69, pay: $200,800)
-
Is Evolutionary Genomics founder-led company?
Yes, Evolutionary Genomics is a company led by its founder Dr. Walter Messier.
-
How many employees does Evolutionary Genomics have?
As Jul 2024, Evolutionary Genomics employs 2 workers.
-
When Evolutionary Genomics went public?
Evolutionary Genomics, Inc. is publicly traded company for more then 13 years since IPO on 15 May 2012.
-
What is Evolutionary Genomics's official website?
The official website for Evolutionary Genomics is evolgen.com.
-
Where are Evolutionary Genomics's headquarters?
Evolutionary Genomics is headquartered at 1026 Anaconda Drive, Castle Rock, CO.
-
How can i contact Evolutionary Genomics?
Evolutionary Genomics's mailing address is 1026 Anaconda Drive, Castle Rock, CO and company can be reached via phone at +7 209008666.
Evolutionary Genomics company profile:

Evolutionary Genomics, Inc.
evolgen.comOTC
2
Biotechnology
Healthcare
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.
Castle Rock, CO 80108
CIK: 0000884363
ISIN: US30051F1012
CUSIP: 30051F101